Thiazole Compounds as Antiviral Agents: An Update

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Chemistry

Background:

• Thiazole derivatives exhibit diverse pharmaceutical applications, including antioxidant, antibacterial, and anticancer activities.
• The thiazole scaffold is present in numerous FDA-approved and experimental drugs, underscoring its medicinal importance.
• While thiazoles show significant antiviral potential, a focused review of recent antiviral literature is lacking.

Purpose of the Study:

• To compile and review the antiviral literature of thiazole compounds published from 2011 to the present.
• To identify potent thiazole derivatives with significant antiviral activity.

Main Methods:

• Searched the SciFinder database using keywords such as "antiviral," "anti-HIV," and "virus."
• Applied filters for publication year and keywords including "thiazole" and "reviews" to identify relevant literature.
• Selected approximately 50 research articles for comprehensive review.

Main Results:

• Identified specific thiazole compounds (e.g., 8, 25, 40, 62, 72, 73, 91, 112, 113, 131, 137, 175, 198, 200, 201, 213) with potent antiviral activity.
• These compounds demonstrated efficacy against a wide range of viruses, including CVB, SARS, RSV, HCV, HIV-1, and influenza virus.
• The reviewed literature highlights the significant antiviral potential of the thiazole scaffold.

Conclusions:

• Thiazole compounds represent a promising class of antiviral agents.
• Further synthesis and evaluation of novel thiazole derivatives, using active compounds as lead structures, are warranted.
• This review provides a comprehensive overview of thiazole antiviral activities from 2011 to date, guiding future research.